Weight Loss Drugs and Off-Label Use: A Growing Concern in Obesity Treatment
Weight Loss Drugs and Their Appeal
Weight loss drugs, particularly injectable medications, are becoming increasingly popular among adults seeking weight loss solutions. A recent survey from The Ohio State University Wexner Medical Center revealed that 1 in 4 adults would consider using these drugs off-label, primarily due to limited availability and high costs.
Reasons for Off-Label Consideration
- Lower cost (18%)
- Not covered by insurance (15%)
- Unable to get a prescription (9%)
- Lack of availability (6%)
It is crucial for individuals to consult with their doctors before using weight loss drugs. Consulting ensures a personalized approach that considers each individual's medical history. Shengyi Mao, MD, emphasizes the importance of evaluating risks and benefits.
The Role of GLP-1 Receptor Agonists
GLP-1 receptor agonists, such as Ozempic and Wegovy, were initially developed for Type 2 diabetes. They help with weight loss by curbing appetite and slowing stomach emptying, also showing potential in lowering cardiovascular risks.
FDA Warnings on Compounded Semaglutide
This year, the FDA issued warnings about compounded semaglutide, alerting users to the risks associated with dosage inaccuracies and counterfeit drugs.
Conclusion: A Tailored Approach to Obesity
Obesity should be treated comprehensively. The effectiveness of weight loss drugs varies, and lifestyle changes are critical for maintaining weight loss over time. Consulting with healthcare professionals remains key to effective obesity management.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.